New Financings in Medical Technology, from MedMarket Diligence, LLC

2012 March, Medical Technology Financings

pjd@mediligence.com — Fri, 20 Apr 2012 07:46:45 -0700

Medical technology financings during the month of March 2012:

Sientra, Inc., has raised $65 million in a Series C round of funding according to the company
ViewRay, Inc., has raised $45 million in a Series C round of funding
Aastrom Biosciences, Inc., has raised $40 million in a round of funding according to a regulatory filing
Myoscience, Inc., has raised $33 million in a Series D funding according to the company
Promethera Biosciences has raised $31.4 million in a round of funding according to press reports
Relievant Medsystems, Inc., has raised $30 million in a Series D funding, according to the company
Omni Surgical, LLC (dba "Spine360") has raised $27 in debt funding according to the company
Sequent Medical, Inc., has raised $26 million in a Series C financing according to the company
LensAR, Inc., has raised $24 million in a round of funding according to press reports
Osprey Medical is raising $21.2 million (A$20 million) in an Australian public offering according to the company
Organovo Holdings has raised $15.2 million in a round of funding according to a regulatory filing
Veniti Medical, Inc., has raised $15 million in a round of funding according to press reports
Glumetrics, Inc., has raised $13.3 million of a planned $19.1 million round of funding according to a regulatory filing
BiO2 Medical, Inc., has raised $13.2 million in a round of funding according to a regulatory filing
Tepha Inc. has raised $11.3 million in funding according to a regulatory filing
Athersys, Inc., has raised $9 million in a round of funding according to a regulatory filing
Vascular Dynamics, Inc., has raised $8.6 million of a planned $15.3 million round of funding according to a regulatory filing
CardioInsight Technologies, Inc., has raised $7.5 million in a round of funding according to the company
Seno Medical Instruments, Inc., has raised $7.36 million of a planned $12 million round of funding according to a regulatory filing
Solace Therapeutics, Inc., has raised $7 million of a planned $20 million round of funding according to a regulatory filing
International Stem Cell Corp. has raised $5 million in a round of funding according to a regulatory filing
Icon Medical Corp. has raised $5 million in a round of funding according to press reports
AtheroMed, Inc., has raised $4.48 million in a round of funding according to a regulatory filing
InControl Medical LLC has raised $3.2 million in a round of funding according to press reports
TItan Medical, Inc., has raised $2.12 million of a planned $4.6 million round of funding according to a regulatory filing
Sapheon, Inc., has raised $1.3 million in a round of funding according to press reports
Obalon Therapeutics, Inc., has raised $1.5 million in a round of funding according to a regulatory filing
Thermedical, Inc., has raised $1.5 million in funding according to a regulatory filing
Celmatix, Inc., has raised $1.5 million in a round of funding according to a regulatory filing
RadioMedix, Inc., has raised $1.4 million in a second tranche of funding from the State of Texas Emerging Technology Fund according to press reports
Life Core Technologies has raised $1 million in a Series A round of funding according to the company
Siesta Medical, Inc., has raised $1 million in a round of funding according to a regulatory filing
IDev Technologies, Inc., has raised $831K of a $950K round of funding according to a regulatory filing
Spinal Simplicity has raised $600K from the Kansas Bioscience Authority according to press reports
Respiratory Technologies, Inc., has raised $500K in a round of funding according to a regulatory filing
Core Essence Orthopaedics, Inc., has raised $432K of a planned $700K round of funding according to a regulatory filing
Pluromed, Inc., has raised $425K of a planned $2 million round of funding according to a regulatory filing
Bongiovi Medical & Health Technologies, LLC, has raised $225K of a planned $5 million round of funding

Source: MedMarket Diligence, LLC

MedMarket Diligence Reports

Coming in May 2012:

Worldwide Wound Management, Forecast to 2018: Established and Emerging Products, Technologies and Markets in the Americas, Europe, Asia/Pacific and Rest of World. May 2012

New:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. February 2012

Other Reports:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.
Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities
Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.
Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2012 February, Medical Technology Financings

pjd@mediligence.com — Wed, 04 Apr 2012 15:25:57 -0700

Medical technology financings during the month of February 2012:

Apollo Endusurgery, Inc., has raised $52.7 million in a round of a $53.8 million round of funding according to press reports
Amplitude Systèmes has raised $39 million (€30 million) in an equity round of funding
Halt Medical, Inc., has raised $20 million of a planned $50 million round of funding, according to the company
Tenex Health, Inc., has raised $11.8 million in a private round of funding according to the company
Velomedix, Inc., has raised $10.2 million in a Series B round of funding according to the company
Cayenne Medical, Inc., has raised $10 million in a round of funding according to a regulatory filing
ALung Technologies, Inc., has raised $10 million in a Series B round of funding according to press reports
Pulmonx has raised $10 million in a round of funding according to a regulatory filing
VytronUS, Inc., has raised $8.7 million of a planned $13 million round of funding according to a regulatory filing
SafeStitch Medical, Inc., has raised $8.3 million in a round of funding according to press reports
Paradigm Spine, LLC, has raised $8.15 million of a planned $14.6 million round of funding according to a regulatory filing
TriVascular, Inc., has raised $7.2 million in a round of funding according to press reports
Vascular Magnetics, Inc., has raised $7 million in a round of funding, according to the company.
Sense A/S has raised $5.9 million (€4.5 million) in a round of seed funding according to press reports
Gynesonics, Inc., has raised $5 million of a planned $7 million round of funding according to a regulatory filing
Amedica Corp. has received $5 million of its $30 million convertible notes financing according to the company
CartiHeal Ltd has raised $5 million in funding according to press reports
Cardium Therapeutics has raised $5 million in a round of funding according to the company
Miracor Medical Systems GmbH has raised $3.5 million (€2.6 million) in research grant and loan funding according to the company
DGIMed Ortho has raised $3.3 million in a debt round of funding according to a regulatory filing
S.E.A. Medical Systems, Inc., has raised $3 million in funding according to the company
Sunshine Heart, Inc., has raised $2.11 million in a round of funding according to a regulatory filing
Second Sight Medical Products, Inc., has raised $2 million in a round of funding according to a regulatory filing
Cervilenz, Inc., has raised $2 million of a planned $3 million round of funding according to a regulatory filing
IntelliCell Biosciences, Inc., has raised $2 million of a planned $3.5 million round of funding according to a regulatory filing
Reset Medical, Inc., has raised $1.5 million in a round of funding according to a regulatory filing
Intact Vascular, LLC (formerly Tackit Vascular), has raised $1.25 million of a planned $3 million round of funding
MetaModix, Inc., has raised $994K of a planned $1.88 million round of funding according to a regulatory filing
Profound Medical, Inc., has raised $867K in an interest-free loan from Canada's Federal Economic Development Agency for Southern Ontario
Sarentis Ophthalmic, Inc., has raised $426K in a round of funding according to a regulatory filing
OptMed, Inc., has raised $321K of a planned $2 million round of funding according to a regulatory filing
Ultrasound Medical Devices, Inc., has raised $313K of a planned $2 million round of funding according to a regulatory filing

Source: MedMarket Diligence, LLC

MedMarket Diligence Reports

New, February 2012, from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. February 2012

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.
Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities
Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.
Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2012 January, Medical Technology Financings

pjd@mediligence.com — Wed, 04 Apr 2012 15:15:56 -0700

Medical technology financings during the month ofJanuary 2012:

ConforMIS has raised $89 million in a Series E round of funding according to the company
Aria Diagnostics, Inc., has raised $52.7 million in a round of funding according to a regulatory filing
Mevion Medical Systems has raised $45 million in a round of funding according to the company
CytoPherx, Inc. has raised $34 million in a round of funding according to press reports
Arena Pharmaceuticals, Inc., has raised $33 million in an offering of common and preferred stock, according to the company
Avinger, Inc., has raised $22.5 million in a round of funding according to the company
Neurologica Corp. has raised $12 million in a round of funding according to a regulatory filing
GluSure Ltd has raised $10.9 million in a Series C round of funding according to the company
Active Implants, Inc., has raised $10 million in funding according to press reports
AirXpanders, Inc., has raised $10.3 million of planned $11 million Series D round of funding, according to press reports
Carticept Medical, Inc., has raised $9.6 million of a $10 million in a Series C round of funding according to a regulatory filing
VertiFlex, Inc., has raised $8 million in a round of funding according to a regulatory filing
Tissue Genesis, Inc., has raised $7.74 million of a planned $15 million round of funding according to a regulatory filing
DiFusion, Inc., has raised $5.28 million of a planned $16 million round of funding according to a regulatory filing
Response Biomedical, Inc., has raised $4.937 million in a round of funding according to a regulatory filing
KeraNetics, Inc., has raised $4.7 million of a planned $7 million funding round according to a regulatory filing
Capricor Inc. has raised $4.5 million of a planned $15 million round of funding according to a regulatory filing
Clearside Biomedical, Inc., has raised $4 million in a round of funding according to press reports
Revent Medical, Inc., has raised $3.5 million of a planned $8.5 million round of funding according to a regulatory filing
Solx, Inc., has raised $3.25 million of a planned $9 million round of funding according to press reports
Checkpoint Surgical has raised $3 million in a Series B funding and a secured non-dilutive funding round according to press reports
SEA Medical Systems, Inc., has raised $3 million in a round of funding according to a regulatory filing
CereScan Corp. has raised $2.83 million of a planned $4 million funding round according to a regulatory filing
Novasys Medical, Inc., has raised $2.8 million of a planned $3 million round of funding according to a regulatory filing
iScience Interventional Corp. has rasied $2.76 million of a planned $5 million round of funding
InCytu, Inc., has raised $1.86 million in funding according to press reports
EpiEP, Inc., has raised $1.6 million of a planned $2.25 million round of funding according to a regulatory filing
JeNu Biosciences, Inc., has raised $1.5 million according to press reports
SafeOp Surgical, Inc., has raised $1.14 million of a planned $4.72 million round of funding according to a regulatory filing
AOI Medical, Inc., has raised $1.12 million in a round of funding according to a regulatory filing
Intact Vascular, Inc., has raised $1.1 million of a planned $1.5 million round of funding according to a regulatory filing
Repiratory Motion, Inc., has raised $781K of a planned $2 million round of funding according to a regulatory filing
Combinent BioMedical Systems, Inc., has raised $750K in a round of funding according to a regulatory filing
Alafair Biosciences, Inc., has raised $702K of a planned $1.5 million round of funding
Metric Medical Devices, Inc., has raised $664K of a planned $1.8 million round of funding according to a regulatory filing
Bioconnect Systems, Inc., has raised $469K of a planned $938K round of funding according to a regulatory filing
nContact Surgical, Inc., has raised $434K in a round of funding according to a regulatory filing
SpecraScience, Inc., has raised $300K of a planned $1.8 million round of funding according to a regulatory filing

Source: MedMarket Diligence, LLC

MedMarket Diligence Reports

Coming February 2012 from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. February 2012

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.
Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities
Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.
Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2011 December, Medical Technology Financings

pjd@mediligence.com — Sun, 01 Jan 2012 09:04:56 -0800

Medical technology financings during the month of December 2011:

HeartFlow, Inc., has raised $64 million of a planned $75 million round of funding according to a regulatory filing
AcuFocus, Inc., has raised $41.87 million in a round of funding according to a regulatory filing
Tissue Regenix Group plc has raised $39 million (£25 million) in a round of funding according to the company
Uptake Medical Corp. has raised $35.1 million of a planned $41.7 million round of funding according to a regulatory filing
Ember Therapeutics has raised $34 million in a Series A round of funding according to press reports
Hansen Medical, Inc., has secured a $30 million debt facility Oxford Finance and Silicon Valley Bank
Cohera Medical, Inc., has raised $25 million in a Series C round of funding, according to the company
CA Medical has raised $20.5 million in a Series B round of funding, according to press reports
Svelte Medical Systems, Inc., has raised $18.78 million of a planned $35 million round of funding according to a regulatory filing
Aspire Bariatrics, LLC, has raised $16 million of a planned $20 million round of funding
Celsion is raising $15 million in a private placement according to press reports
TransEnterix, Inc., has raised $14.89 million of a planned $15 million round of funding according to a regulatory filing
BeneChill, Inc., has raised $14.84 million of a planned $25.59 million round of funding according to a regulatory filing
Sotera Wireless has raised $12.2 million in its fourth round of financing according to the company
Medrobotics Corp. (formerly Cardiorobotics, Inc.) has raised $11.7 million in a Series C round of funding according to the company
Velomedix, Inc., has raised $9.3 million of a planned $10.7 million round of funding according to a regulatory filing
Cerevast Therapeutics, Inc., has raised $6.56 million of a planned $15.75 million round of funding according to a regulatory filing
Grove Instruments, Inc., has raised $6 million in a Series B round of funding, according to the company
Endostim, Inc., has raised $5.55 million in a round of funding according to a regulatory filing
MedLumics has raised $4.7 million (€3.5 million) in a Series A round of funding according to the company
Clear Catheter Systems, Inc., has raised $4 million in a round of funding according to press reports
Pulse Therapeutics, Inc., has raised $3.09 million in a round of funding according to a regulatory filing
Tribogenics, Inc., has raised $2.5 million in a round of funding according to the company
KSpine, Inc., has raised $2.5 million according to press reports
Corinthian Ophthalmic, Inc., has raised $2.28 million in a round of funding according to a regulatory filing
Intuitive BeneChill, LLC, has raised $2 million of a planned $8 million round of funding according to a regulatory filing
Miromatrix Medical, Inc., has raised $2 million of a planned $3 million funding round, according to a regulatory filing
Uromedica, Inc., has raised $1.25 million in a round of funding according to a regulatory filing
Islet Sciences, Inc., has raised $1.1 million in a round of funding according to a regulatory filing
Nano Vibronix, Inc., has raised $1 million in a round of funding according to a regulatory filing
Tolera Therapeutics, Inc., has raised $883K of a planned $1.65 million round of funding according to a regulatory filing
Allurion Technologies, Inc. (formerly SLG Medical) has raised $750K in funding according to press reports
Preceptis Medical, Inc., has raised $500K of a planned $1.5 million round of funding according to a regulatory filing
Physcient, Inc., has raised $300K of a planned $4 million round of funding according to a regulatory filing
BrainScope Co., Inc., has raised $250K from the Maryland Venture Fund

Source: MedMarket Diligence, LLC

MedMarket Diligence Reports

Coming January 2012 from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. January 2012

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.

Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities

Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.

Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

Medtech financings by month 2010 and 2011

pjd@mediligence.com — Mon, 05 Dec 2011 14:10:34 -0800

Below are links to each month's tables of individual medical technology company financings for 2010 to 2011.:

2011 Medtech Financings by Month

Month	Financings ($millions)	Detail
January	$305	link
February	$656	link
March	$309	link
April	$272	link
May	$572	link
June	$494	link
July	$467	link
August	$410	link
September	$423	link
October	$350	link
November	$405	link
December	--	--
Total (to date)	$4,663	--

2010 Medtech Financings by Month

Month	Financings ($millions)	Detail
January	$514	link
February	$160	link
March	$241	link
April	$125	link
May	$432	link
June	$312	link
July	$518	link
August	$267	link
September	$249	link
October	$316	link
November	$127	link
December	$332	link
Total	$3,593	--

Report coming soon from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. December 2011

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.

Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities

Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.

Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2011 November, Medical Technology Financings

pjd@mediligence.com — Mon, 05 Dec 2011 14:10:20 -0800

Medical technology financings during the month of November 2011:

Vention Medical, Inc., has raised $77.3 million in a round of funding according to a regulatory filing
AcuFocus, Inc., has raised $65 million in a round of funding, according to press reports
Sensors for Medicine, Inc., has raised $54.1 million in a Series D financing according to the company
Pivot Medical has received $32 million in a Series C funding according to the company
CircuLite, Inc., has raised $30 million in a Series D financing according to press reports
DFine, Inc., has raised $25 million in a round of funding according to the company
Sphere Medical Ltd has raised $22.3 million (£14 million) in a new round of funding according to the company
Ophthonix, Inc., has raised $14 million of a planned $15 million round of funding according to a regulatory filing
Sapiens Steering Brain Stimulation GmbH has raised $13.39 million (€10 million) in a round of funding according to the company
Hansen Medical, Inc., is raising $10 million in a private placement, according to the company
Veryan Medical has raised $6.86 million (€5 million) in a round of funding according to press reports
ALung Technologies, Inc., has raised $6.61 million of a planned $10 million round of funding
Cohera Medical, Inc., has raised $6.25 million of a planned $11.29 million in a round of funding according to a regulatory filing
BioMers Products, LLC, has raised $4.84 million (6 million Singapore dollars) in a round of funding according to the company
Tangent Medical Technologies, Inc., has raised $4.5 million in a Series A financing according to press reports
IlluminOss Medical, Inc., has raised $4 million in a round of funding according to a regulatory filing
ENTrigue Surgical, Inc., has raised $4 million in a round of funding according to a regulatory filing
Lazure Scientific, Inc., has raised $3.15 million of a planned $6 million round of funding according to a regulatory filing
Inova Labs, Inc., has raised $3.1 million of a planned $17.5 million in a round of funding according to a regulatory filing
Arsenal Vascular, Inc., has raised $3 million in funding according to a regulatory filing (in addition to $3M raised in Sept. 2011)
Flexuspine, Inc., has raised $2.1 million in a round of funding according to a regulatory filing
Telcare, Inc., has raised $1.49 million in a round of funding according to a regulatory filing
Plurogen Therapeutics, Inc., has raised $1.23 million of a planned $3 million round of funding according to a regulatory filing
Convergent Radiotherapy, LLC, has raised $1.2 million of a planned $6.2 million round of funding
Rhinocyte, Inc., has raised $1.1 million of a planned $2 million round of funding according to a regulatory filing
Olive Medical Corp. has raised $1 million in a round off funding according to a regulatory filing
Nitric BioTherapeutics, Inc., has raised $1 million in a round of funding according to a regulatory filing
Tarsus Medical, Inc., has raised $1 million in a round of funding according to a regulatory filing
Flexible Medical Systems, LLC, has raised $923K of a planned $1 million round of funding according to a regulatory filing
EndoSee Corporation has raised $887K of a planned $1 million round of funding according to a regulatory filing
LabStyle Innovations Corp. has raised $805K of a planned $3 million round of funding according to a regulatory filing
Cardiac Insight, Inc., has raised $700K in a round of funding according to a regulatory filing
St. Teresa Medical, Inc., has raised $470K of a planned $1.5 million round of funding according to a regulatory filing.
Soteira, Inc., has raised $469K of planned $525K in a round of funding, according to a regulatory filing
Ablative Solutions, Inc., has raised $457K of a planned $1.5 million round of funding according to a regulatory filing
DGIMED ORTHO, Inc., has raised $451K of a planned $2.1 million round of funding according to a regulatory filing
NanoVibronix, Inc., has raised $300K from Tegal Corp. in a private funding according to the companies
Forge Medical, Inc., has raised $180K of a planned $600K round of funding according to a regulatory filing

Source: MedMarket Diligence, LLC

Report coming soon from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. December 2011

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.

Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities

Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.

Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2011 October, Medical Technology Financings

pjd@mediligence.com — Mon, 05 Dec 2011 14:10:51 -0800

Medical technology financings during the month of October 2011:

Nuvasive, Inc., has raised $40.46 million in a round of funding according to a regulatory filing
Autonomic Technologies, Inc., has raised $32.13 million in a round of funding, according to a regulatory filing
NxThera, Inc., has raised $21.6 million in a Series B round of funding, according to the company
Kips Bay Medical, Inc., has raised $20 million in a round of funding according to press reports
Apnex Medical, Inc., has raised $20 million of a planned $35 million round of funding according to a regulatory filing
OrthoPediatrics Corp. has raised $20 million in a round of funding
Arsenal Medical, Inc. (soon to be named Arsenal Vascular) has raised $18 million in a round of funding associated with the spinoff of 480 Biomedical, a company to be focused on occlusive disease in the femoral artery.
CV Ingenuity has raised $16 million in a Series B round of funding according to the company
TearScience has raised $15 million in debt financing according to press reports
Dfine, Inc., has raised $14.98 million of a planned $26.5 million round of funding according to a regulatory filing
EverHeart Systems, Inc., has raised $11.65 million in a round of funding according to a regulatory filing
Functional Neuromodulation, Inc., has raised $10.4 million in new funding according to the company
Interrad Medical, Inc., has raised $10 million in a Series C round of funding according to the company
Phagenesis Ltd has raised $9.3 million (€7 million) in a Series B round of funding according to the company
Veryan Medical has raised $8.05 million (£5 million) in a new round of funding according to press reports
Lonestar Heart, Inc., has raised $7.45 million of a planned $20 million round of funding according to a regulatory filing
TiGenix subsidiary Cellerix SA has raised $6.57 million in financing from the Madrid Network according to the company
CoDa Therapeutics, Inc., has secured a $6 million credit facility according to the company
CHF Technologies, Inc., has raised $5.05 million of a planned $10 million round of funding according to a regulatory filing
Calhoun Vision, Inc., has raised $5.13 million of a planned $7.3 million round of funding according to a regulatory filing
Bind BIosciences, Inc., has raised $4.5 million in debt financing according to a regulatory filing
ImThera Medical, Inc., has raised $4 million of a planned $16 million round of funding according to a regulatory filing
O2 Medtech, Inc. has raised $3.61 million of a planned $5.11 million round of funding according to a regulatory filing
Nervomatrix Ltd has raised $3.5 million in a Series A round of funding according to press reports
Organovo, Inc., has raised $3.49 million in a round of funding according to a regulatory filing
CerviLenz, Inc., has raised $3.475 million in a round of funding according to a regulatory filing
EndoEvolution, LLC, has raised $3.3 million in a Series B round of funding according to the company
Acutus Medical, Inc., has raised $3.28 million of a planned $4.58 million round of funding according to a regulatory filing
BioInspire Technologies, Inc., has raised $3.12 million in a round of funding according to a regulatory filing.
Titan Spine, LLC, has raised $2.64 million in a round of funding according to a regulatory filing
Endoclear LLC has raised $2.4 million of a planned $4 million round of funding according to a regulatory filing
Orthobond, Inc., has raised $21.5 million in a round of funding according to a regulatory filing
VisionGate, Inc., has raised $1.96 million of a planned $3 million round of funding according to press reports
Allocure, Inc., has raised $1.5 million in a round of funding according to a regulatory filing
Domain Surgical, Inc., has raised $1.475 million of a planned $3 million round of funding according to a regulatory filing
Chesson Labs has raised $1.45 million in an expansion of its second round of funding, according to press reports
Hyperbranch Medical Technology, Inc., has raised $1.04 million in a round of funding according to a regulatory filing
MX Orthopedics, Inc., has raised $1 million in a round of funding according to a regulatory filing
SPR Therapeutics, LLC, has raised $1 million of a planned $2 million round of funding according to a regulatory filing
Cardero Therapeutics, Inc., has raised $1 million of a planned $10.3 million round of funding according to a regulatory filing
AxoGen, Inc., has raised $1 million in a round of funding according to a regulatory filing
Salutaris Medical Devices, Inc., has raised $700K in a round of funding according to a regulatory filing
Entegrion, Inc., has raised $300K of a planned $5.1 million round of funding
Oculeve, Inc., has raised $200K of a planned $300K round of funding according to a regulatory filing

Source: MedMarket Diligence, LLC

Report coming soon from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. December 2011

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.

Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities

Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.

Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2011 September, Medical Technology Financings

pjd@mediligence.com — Mon, 05 Dec 2011 14:11:08 -0800

Medical technology financings during the month of September 2011:

Valeritas, Inc., has raised $150 million in a Series C round of funding according to the company
GI Dynamics, Inc., has raised $37.5 million in a round of funding according to a regulatory filing
CardioKinex, Inc., has raised $24.56 million of a planned $44.76 million Series E financing according to the company
Simpirica Spine, Inc., has raised $22 million in a Series C financing according to press reports
Avinger, Inc., has raised $21.15 million of a planned $30.08 million round of funding according to a regulatory filing
Trans1, Inc., has raised $18.3 million in a stock offering
SI-BONE, Inc., has raised $16 million in a round of funding according to the company
EnteroMedics, Inc., has raised $14.5 million in a public offering
RF Surgical Systems, Inc., has raised $12 million in funding according to a regulatory filing
Arsenal Vascular, Inc. (formerly Arsenal Medical) has raised $12 million of a planned $18 million round of financing according to a regulatory filing
superDimension Ltd. has raised $11 million in funding according to press reports
Miracor Medical Systems GmbH has raised $10 million (€7 million) in a Series B round of funding according to press reports
Glucotec, Inc., has raised $8.27 million of a planned $10 million round of funding according to a regulatory filing
SpineGuard has raised $6.2 million in a new round of funding according to the company
Noveko International has raised $6 million in funding according to the company
Altura Medical, Inc., has raised $6 million in a round of funding according to a regulatory filing
Advanced Cardiac Therapeutics, Inc., has raised $5.96 million of a planned $13.46 million round of funding according to a regulatory filing
C8 Medisensors Ltd has raised $4.26 million of a planned $14.1 million round of funding according to a regulatory filing
ValveXchange, Inc., has raised $4.03 million in a round of funding according to a regulatory filing
MicroMed Cardiovascular, Inc., has raised $3.75 million of a planned $4.28 million round of funding according to a regulatory filing
Cardiosolutions, Inc., has raised $3.3 million of a planned $6.5 million round of funding according to a regulatory filing
Vycor Medical, Inc., has raised $2.95 million in a round of funding according to a regulatory filing
Atlanta Catheter Therapies, Inc., has raised $2.98 million in a Series A financing according to a regulatory filing
Medspira, Inc., has raised $2.25 million according to press reports
NeoSurgical Ltd. has raised $2.19 million (€1.6 million) in a round of funding according to press reports
Halt Medical, Inc., has raised $2 million in a round of funding according to a regulatory filing
Oncoscope, Inc., has raised $2 million in funding according to a regulatory filing
Femasys, Inc., has raised $1.75 million of a planned $10 million round of funding according to a regulatory filing
Colibri Heart Valve LLC has raised $1.56 million of a planned $5 million round of funding according to a regulatory filing
Gen9, Inc., has raised $1.55 million of a planned $9.59 million round of funding according to a regulatory filing
Prospex Medical III, Inc., has raised $1.5 million of a planned $4 million round of funding according to a regulatory filing
Soft Tissue Regeneration, Inc., has raised $1.25 million of a planned $2.5 million round of funding according to a regulatory filing
Tangent Medical Technologies, Inc., has raised $1 million in funding according to a regulatory filing
BioSIg Technologies, Inc., has raised $922K of a planned $1 million round of funding according to a regulatory filing
Generic Medical Devices, Inc., has raised $906K of a planned $3.55 million round of funding according to a regulatory filing
Impel Neuropharma has raised $527K of a planned $2 million round of funding
Sight Sciences, Inc., has raised $525K of a planned $5.25 million round of financing according to a regulatory filing
Endoclear LLC has raised $500K in a round of funding according to a regulatory filing
Scion Cardio-Vascular, Inc., has raised $200K of a planned $2 million round of funding according to a regulatory filing

Source: MedMarket Diligence, LLC

Report coming soon from MedMarket Diligence, LLC:

Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017. December 2011

Other Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.

Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities

Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.

Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

2011 August, Medical Technology Financings

pjd@mediligence.com — Thu, 01 Sep 2011 12:46:59 -0700

Medical technology financings during the month of August 2011:

NeuroPace, Inc., has raised $49.13 million of a planned $61.91 million round of financing according to a regulatory filing (Implantable devices for treating epilepsy and other neurological disorders by responsive brain stimulation)
VIVUS, Inc., has raised $45.8 million in funding from a registered direct offering (Pharmaceuticals for obesity, sleep apnea, diabetes and other conditions)
Restoration Robotics, Inc., has raised $41 million in a Series C round of funding according to press reports (Image guidance system for use in hair transplantation)
Entellus Medical, Inc., has raised $35 million in a round of funding according to a regulatory filing (Minimally invasive treatment of sinusitis)
Vessix Vascular, Inc., has raised $23 million in a round of funding according to press reports (RF balloon catheter technology for treatment of peripheral vascular occlusions)
AccuVein, Inc. has raised $22.96 million in a new round of funding, according to a regulatory filing (Vein illumination device to facilitate access)
Fibrocell Science, Inc., has raised $22.8 million in a round of funding according to a regulatory filing (Autologous cell therapies for aesthetic, medical and scientific applications)
Occlutech has raised €15 million ($21.7 million) in a round of funding according to the company (Implants for treatment of patent foramen ovale and other heart defects)
Ellipse Technologies, Inc., has raised $17.6 million in a Series C round of funding according to press reports (Implants for treatment of orthopedic deformity and trauma)
Bacterin International Holdings has secured a $15 million credit facility (Bone graft material and anti-infective coatings)
Aleve Therapeutics SA has raised €9.5 million ($13.66 million) in a Series A round of funding according to the company (Deep brain stimulation)
Tandem Diabetes Care, Inc., has raised $12 million of a planned $13.7 million round of funding according to a regulatory filing (Insulin pumps for diabetes)
ViewRay, Inc., has raised $10.34 million in a round of funding from existing investors according to press reports (Magnetic resonance imaging combined with gamma ray radiotherapy)
Cardiox Corp. has raised $8 million in a round of funding according to a regulatory filing (Non-invasive diagnostics for prevention of stroke)
TransMedics, Inc., has raised $5.9 million of a planned $22.5 million round of funding according to a regulatory filing. (Technologies to sustain organs for transplant)
Neograft Technologies, Inc., has raised $5 million in funding according to press reports (Angioshield technology to protect harvested veins during graft procedures)
Beacon Endoscopic, Inc., has raised $5 million in a Series B round of funding according to a regulatory filing (Technologies for interventional endoscopic procedures)
Sunshine Heart, Inc., has raised $4.97 million of a planned $15 million funding round according to a regulatory filing (Minimally invasive treatment of heart failure)
Ascendx Spine, Inc. (formerly AOI Medical), has raised $4.8 million in "mixed" (cash and debt converted to equity) funding according to the company (Technology for treatment of vertebral compression fractures)
InterValve, Inc., has raised $4.73 million of a planned $8 million funding round according to a regulatory filing (Catheter-based treatment of calcified aortic valve stenosis)
BIO2 Medical, Inc., has raised $4.58 million of a planned $5.22 million round of funding according to a regulatory filing (Catheter for the prevention of pulmonary embolism)
Rox Medical, Inc., has raised $4 million in a round of funding according to a regulatory filing (Technology to increase oxygenation for patients with COPD)
Lantos Technologies, Inc., has raised $4 million in a round of funding according to a regulatory filing (3-D intra-aural scanner)
Hotspur Technologies, Inc., has raised $3.5 million of a planned $4 million round of funding according to a regulatory filing (Catheter technologies including for angioplasty and embolectomy)
PneumaCare Ltd. has raised £2 million in a new round of funding according to press reports (Non-contact respiratory diagnostic technology)
Innocoll Holdings has raised $3.25 million in a round of funding according to a regulatory filing (Collagen-based, biodegradable surgical implants and topically applied healthcare products)
Claret Medical, Inc., has raised $3 million of a planned $3.5 million round of funding according to a regulatory filing (Cerebral vascular protection device for Transcatheter Aortic Valve Implant (TAVI) procedures)
AliveCor, Inc., has raised $3 million in a Series A round of funding according to press reports (Wireless ECG recorder)
iScience Interventional Corp. has raised $3 million in funding according to a regulatory filing (Interventional ophthalmology technologies)
Aura Biosciences, Inc., has raised $2.93 million in a round of funding according to a regulatory filing (Nanotechnology-based drug delivery technologies)
InspireMD, Inc., has raised $1.5 million in a round of funding according to a regulatory filing (Stent for high risk coronary patients)
NuPathe, Inc., has raised $1.1 million of a planned $30.6 million round of funding according to a regulatory filing (Transdermal patch for the treatment of migraine)
Acutus Medical, Inc., has raised $1 million in a round of funding according to press reports (Cardiac arrhythmia mapping technology)
Medifocus, Inc., has raised $1 million in a private placement according to the company (Microwave treatment of cancerous tumors)
Cellerant Therapeutics, Inc., has raised $800K of a planned $1.6 million round of funding according to a regulatory filing (Cell-based hematopoietic therapeutics for treatment of cancer and other applications)
Endotronix, Inc., has raised $740K of a planned $2 million round of funding according to a regulatory filing (Wireless cardiovascular monitoring for congestive heart failure)
Oxtexs Limited has raised £365 in funding according to press reports (Hydrogel material for tissue expansion)
Windmill Cardiovascular Systems, Inc., has raised $500K of a planned $2.2 million round of funding according to a regulatory filing (Left ventricular assist devices for heart failure)
NovaTract Surgical, Inc., has raised $500K in seed funding according to press reports (Single incision laparoscopic surgery and natural orifice transluminal endoscopic surgery)

Source: MedMarket Diligence, LLC

Reports from MedMarket Diligence:

Worldwide Spine Surgery 2011: Products, Technologies, Markets & Opportunities, Worldwide, 2010-2020 .July 2011.

Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019. February 2011.
Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2008-2015
Diabetes Management: Products, Technologies, Markets and Opportunities in Diabetes Management Worldwide, 2009-2018
Ablation Technologies: Ablation Technologies Worldwide Market, 2009-2019: Products, Technologies, Markets, Companies and Opportunities

Tissue Engineering, Cell Therapy and Transplantation: Products, Technologies & Market Opportunities, Worldwide, 2009-2018.

Worldwide Wound Management Market, 2009: Established and Emerging Products, Technologies and Markets for Wound Management in the U.S., Europe, Japan and Rest of World, 2008-2017.
Worldwide Market for Coronary Stents, 2008-2017: Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017.

For additional details on Reports or the Medtech Startups Database, contact Patrick Driscoll at +1-949-859-3401 or patrick(at)mediligence(dot)com.

Venture Capitalists with Healthcare Investment

pjd@mediligence.com — Mon, 25 Oct 2010 14:53:50 -0700

Follow the money...

Below is an updated list of venture capital sites with investment in healthcare. In most cases, the links provided are for each VC firm's current portfolio. (While we update this list daily, we provide no guarantee that all links below are current, nor that this is an exhaustive list.)

Source: MedMarket Diligence, LLC

Reports:

2010 September, Medical Technology Financings

pjd@mediligence.com — Fri, 1 Oct 2010 11:36:16 -0700

Medical technology financings during the month of September 2010:

Accumetrics, Inc., has raised $24 million in funding from existing investors (devices to measure antiplatelet therapy)
SyneCor, LLC, has raised $10 million in funding according to a regulatory filing (device technologies in interventional cardiology)
Second Sight Medical Products, Inc., has raised $1.5 million of a planned $3 million round of funding according to a regulatory filing (retinal prosthesis)
superDimension Ltd. has raised $24.8 million ($9.8 million equity and $15 million credit) in financing (minimally invasive interventional pulmonology devices)
Amedica Corp. has raised $30 million ($15 million each in debt, equity) in financing (spine and total joint implants)
CardioRobotics, Inc., has raised $500K of a planned $5 million round of financing (surgical robotics)
ECW Therapeutics, Inc., has raised $200K of a planned $500K in funding (autologous stem cell systems)
MAX Endoscopy, Inc., has received $250K in funding from JumpStart, Inc. (fiberoptic device for treatment of hemorrhoids)
BioTectix, LLC, has received $3 million in investment from founding investment firm Allied Minds (polymer materials and coatings for implantable medical devices)
Orthopedic Designs North America, Inc., has received $3 million in funding according to a regulatory filing (orthopedic fixation devices)
Humacyte, Inc., has raised $12 million in funding according to a regulatory filing (tissue engineering)
CardioMEMS has received a $60 million investment from St. Jude Medical (MEMS technology for cardiovascular disease, including congestive heart failure, and others)
SonarMed, Inc., has raised $1.03 million in funding according to a regulatory filing (technologies to aid intubation)
Guided Therapeutics, Inc., has raised $3.055 million of a planned $5 million round of funding according to a regulatory filing (technologies to detect precancerous cervical disease)
CloSys Corp. has raised $1.49 million of a planned $2.38 million round of investment (vascular closure devices)
Tryton Medical has received $20 million in a Series D round of funding (stents for bifurcated lesions)
Lantos Technologies, Inc., has raised $1.6 million in funding according to regulatory filing (3D imaging of ear canal)
DGIMED ORHTO, Inc., has raised $1.56 million of a planned $3.5 million funding round according to a regulatory filing (orthopedic implants)
CardiaLen, Inc., has raised $305K in funding according to a regulatory filing (cardioverters for atrial fibrillation)
Arterial Remodeling Technologies has raised $8.5 million in a new funding round (fully resorbable coronary stents)
Sadra Medical, Inc., has raised $4 million in funding according to a regulatory filing (endovascular aortic valve replacement)
Orthocare Innovations has raised $3 million in funding according to a regulatory filing (orthotics and prosthetics based on sensor and actuation technologies)
Aura Biosciences, Inc., has raised $1.425 million according to a regulatory filing (nanotechnology based drug delivery)
Glaukos Corp. has raised $6 million in funding according to a regulatory filing (technologies for treatment of glaucoma)
Rhythmia Medical, Inc., has raised $5 million of a planned $7 million funding round according to a regulatory filing (device treatment for cardiac arrhythmia)
ProUroCare Medical, Inc., has raised $3 million in financing (prostate imaging system)
Transave Inc. has raised $2 million of a planned $6 million round according to a regulatory filing (liposomal drug delivery)
Cabochon Aesthetics, Inc., has raised $1.4 million of a planned $2 million round of funding (medical devices for the aesthetic treatment of cellulite)
Ophthonix, Inc., has raised $5.4 million of a planned $12.1 million funding round (vision correction)
Anaxsys Ltd. has raised $1.58 million (£1 million) in funding (respiratory sensor devices for asthma, sleep apnea and lung cancer)
EnteroMedics, Inc., has raised $6.3 million in a Series A funding round (neuroblocking devices for treatment of obesity and other GI diseases)
Caymus Medical, Inc., has raised $1 million in funding (undisclosed medical technology from previous founder of Opus Medical)
Combinent BioMedical Systems, Inc., has raised $500K in funding according to a regulatory filing (transvaginal drug delivery system)
Ellipse Technologies, Inc., has raised $1.58 million of a planned $2 million round of funding (system for treatment of spinal scoliosis)

Source: MedMarket Diligence, LLC

Reports:

2010 August, Medical Technology Financings

pjd@mediligence.com — Wed, 15 Sep 2010 13:37:13 -0700

Medical technology financings during the month of August 2010:

Fibrocell Science, Inc., has raised $2.7 million in a round of funding according to a regulatory filing (autologous cell therapies)
SpectraScience, Inc., has raised $3.15 million of a planned $5 million round of funding according to a regulatory filing ("optical biopsy" cancer detection)
NXThera, Inc., has raised $1 million in funding according to a regulatory filing (minimally invasive treatment of benign prostatic hypertrophy and other men's health)
SPO Medical, Inc., has raised $438K of a planned $1.02 million round of funding (reflectance pulse oximetry)
ImThera Medical, Inc., has raised $3.5 million in a round of funding according to a regulatory filing (neurostimulation for treatment of sleep apnea)
Cardioxyl Pharmaceuticals, Inc., has raised $15 million in funding (heart failure drug)
Paringenix, Inc., has raised $4.39 million of a planned $5 million round of funding according to a regulatory filing (developing a modified form of heparin to ameliorate cardiac ischemia-reperfusion injury following myocardial infarction)
Clear Vascular, Inc., has raised $5.42 million in funding according to a regulatory filing (Implant for the treatment of luminal hyperplasia)
InspireMD Ltd. has raised $1.58 million in funding according to a regulatory filing (stents for myocardial infarction, carotid intervention and other vascular and non-vascular applications)
Neodyne Biosciences, Inc., has raised $5.76 million in funding according to a regulatory filing (investigational device for post-surgical incision care)
Nephera, Inc., has raised $2.85 million in its second round of funding (device for treatment of congestive heart failure)
Orthos, Ltd, has raised $1.3 million in a round of funding (bone substitutes)
SI-BONE, Inc., has raised $11 million in a round of funding (minimally invasive device for treatment of the sacroiliac joint)
nContact Surgical, Inc., has raised $4 million in a round of funding according to a regulatory filing (endoscopic treatment of arrhythmia)
Cardiac Concepts, Inc., has raised $27.2 million in funding according to a regulatory filing (products for treatment of heart failure and sleep apnea)
Domain Surgical, Inc., has raised $1.255 million in funding according to a regulatory filing (development stage medical device company)
Response Biomedical Corp. has received $7.725 million in funding according to a regulatory filing (point-of-care diagnostics)
Arsenal Medical, Inc., has raised $3 million in funding according to a regulatory filing (biomaterials-based therapeutics based on bioactive composites)
BenVenue Medical, Inc., has raised $4.45 million of a planned $31 million round of financing (minimally invasive spine surgery)
Mardil, Inc., has raised $1.55 million of a planned $6.5 million funding round according to a regulatory filing (minimally invasive treatment of congestive heart failure)
NeuroVista, Inc., has raised $21.5 million in an equity and convertible debt funding (implantable device for treatment of epilepsy)
ViewRay, Inc., has raised $20 million in a Series C financing (MRI-guided radiotherapy)
Cardiac Concepts, Inc. has raised $27.2 million in funding (neurostimulation device for treatment of congestive heart failure and sleep apnea)
Golden Meditech has raised $40 million in equity funding (autologous blood recovery system)
EndoGastric Solutions, Inc., has raised $30 million in Series F funding (natural orifice surgery)
Aptus Endosystems, Inc., has raised $15 million in a "Series AA" round of funding (endovascular aneurysm repair)
ClearCount Medical, Inc., has raised $5 million in a funding round (RFID-based products for safety in surgical/medical applications)
Femasys, Inc., has raised $1.03 million of a planned $5 million round of financing according to a regulatory filing (fallopian tube and uterine diagnostics)

Source: MedMarket Diligence, LLC

Reports:

2010 July, Medical Technology Financings

pjd@mediligence.com — Sun, 1 Aug 2010 08:57:19 -0700

Medical technology financings during the month of July 2010:

Replication Medical, Inc., has raised $1.1 million in funding according to a regulatory filing (implantable hydrogel devices used in spine surgery)
Sensus Healthcare, LLC, has raised $1.5 million of a planned $7 million round of funding according to a regulatory filing (medical technology development)
Figure 8 Surgical, Inc., has raised $1.36 million of a planned $1.5 million round of funding according to a regulatory filing
Seguro Surgical, Inc., has raised $125K of a planned $1.25 milllion funding round (surgical instrumentation)
Tissue Genesis, Inc., has raised $1.33 million of a planned $15.3 million round of funding according to a regulatory filing (tissue engineering and cell therapy)
BIO2 Technologies has raised $1.1 million of a planned $2 million round of funding (tissue engineering scaffolds)
Smart Pill Corp. has raised $7.95 million of a planned $9.5 million round of funding according to a regulatory filing (pill camera GI diagnostic)
Cambus Medical has raised $1.89 million (€1.5 million) in a new round of funding (advanced catheter component solutions)
Cappella Inc. has raised $3.69 million of a planned $9.9 million round of funding according to a regulatory filing (treatment of bifurcation in coronary artery disease )
Uptake Medical, Inc., has raised $17.5 million in a Series B funding round (device for treatment of emphysema)
Neoprobe Corp. has raised $14 million in funding (gamma detection technology in sentinal node biopsy)
DFine, Inc., has raised $36.2 million in financing (minimally invasive treatments of vertebral compression fractures )
EyeTechCare has raised $9.5 million (€7.5 million) in a new round of funding (high intensity focused ultrasound (HIFU) for treatment of glaucoma )
Theranos, Inc., has raised $45 million of a planned $100 million round of funding (medical devices that monitor drug reactions breathing)
InVasc Therapeutics, Inc., has raised $3.2 million of a planned $12 million round of funding according to a regulatory filing (drugs for kidney disease and atherosclerosis)
Innocoll Holdings, Inc., has raised $5 million in funding according to a regulatory filing (collagen-based drugs and devices)
Vertiflex, Inc., has raised $2 million in funding according to a regulatory filing (non-fusion spine surgery technologies)
Providien, Inc., has raised $10.5 million in seed funding (undisclosed medical device technology, principal investor Endeavor Capital)
BBARRX Medical, Inc., has raised $15 million in a Series D round of funding (endoscopic treatments for GI diseases)
Invuity, Inc., has raised $13.2 million of a planned $16 million round of funding (lighting and visualization in minimally invasive surgical instrumentation)
EndoStim, Inc., has raised $6 million in a Series B financing (device treatment sphincter-related disorders such as GERD and urge uinary incontinence)
Gentis, Inc., has raised $548K of a planned $2.25 million round of funding (orthobiologics products)
AxioMed Spine Corp. has raised $14.5 million in a round of funding (spinal disc implants)
Nfocus Neuromedical, Inc., has raised $3.31 million of a planned $7.15 million funding round (device treatment of brain aneurysms)
Maya Medical, Inc., has raised $700K in an apparent seed financing (company founded by Motasim Sirhan, founder of Avantec Vascular)
inCyte Innovations, LLC, has raised $3 million in funding according to a regulatory filing
SuperDimension Ltd. has raised $9.8 million in a funding round (technology to detect and map lung cancer)
USHIFU, Inc., has raised $1.02 of a planned $10 million funding round according to a regulatory filing (therapeutic use of high intensity focused ultrasound)
Devicor Medical Products Group, LLC, has raised $151.5 million from seven investors to fund development of breast-care business (now named Mammotome) from J&J's Ethicon Endo-Surgery.
IDEV Technologies, Inc., has raised $27.7 million of a planned $44.8 million round of financing according to a regulatory filing (biliary stent technologies)
Sound Surgical Technologies, LLC, has raised $2.1 million of a planned $5 million funding round (ultrasound based liposuction for cosmetic surgery)
Avedro, Inc., has raised $4.58 million in funding according to a regulatory filing (non-invasive procedure for treatment of keratoconus in vision correction)
InfraReDx, Inc., has raised $1.53 million in a round of funding according to a regulatory filing (infrared imaging of blood vessels for catheterization)
Aethlon Medical, Inc., has raised $890K in a round of funding according to a regulatory filing (blood purifier to treat infectious diseases)

Source: MedMarket Diligence, LLC

Reports:

2010 June, Medical Technology Financings

pjd@mediligence.com — Wed, 30 Jun 2010 08:58:45 -0700

NanoPowers SA has raised CHF 5 million ($4.5 million) in a Series A financing (developing artificial muscle technology including for artificial urinary sphincter)
Altura Medical, Inc., has raised an additional $12 million, bringing its current round of funding to $20 million (devices for the treatment of abdominal aortic aneurysm)
Minimus Spine, Inc., has raised $925K of a planned $1.7 million round of funding according to a regulatory filing (ozone injection technology for treatment of spinal disc herniation)
Follica, Inc., has raised $7.5 million in a Series C round of funding (device technology for the treatment of hair follicle disorders)
ZELTIQ has raised $20 million in a Series D funding (device to remove fat via cold lypolysis)
Uptake Medical, Inc., has raised $600K in a round of funding according to a regulatory filing (devices for treatment of emphysema and COPD)
Anulex Technologies, Inc., has raised $18.3 million of a planned $20 million Series E round of funding according to a regulatory filing (technologies to preserve soft tissue of spine for patients undergoing discectomy)
EarlySense Ltd has raised $13 million in funding (non-contact patient monitoring system)
AqueSys, Inc., has closed on $35 million funding in a Series C round (device for treatment of glaucoma)
AtheroNova, Inc., has raised $10.7 million in funding according to a regulatory filing (biopharmaceuticals targeted at atherosclerosis)
NeoVista, Inc., has raised $3.2 million of a planned $12 million round of funding according to a regulatory filing (epiretinal device for treatment of wet AMD)
PorOsteon Orthopedics, Inc., has raised $2.2 million of a planned $2.5 million round of funding (undisclosed orthopedic device technology)
Exogenesis Inc. has raised $3.7 million of a planned $4.1 million round of funding (surface modification technologies for medical devices)
Sebacia, Inc., has raised $2.5 million according to a regulatory filing (medical technology portfolio company of The Innovation Factory)
OptiNose AS has received commitment of $48.5 million in funding from Avista Capital Partners (nasal drug delivery technology)
MoMelan Technologies, Inc., has raised $1.08 million in funding (device to improve skin grafting)
Access Scientific, Inc., has raised $2.6 million of a planned $2.9 million funding round (vascular insertion device)
Lonestar Heart, Inc., has raised $10.2 million of a planned $15 million round of funding according to a regulatory filing (acquired CardioPolymers, developing biocompatible polymer implant therapies for treatment of CHF, valve and fibrillation)
CytoPherx, Inc., has raised $11.7 million of a planned $12 million funding round according to a regulatory filing (cytopheresis device based treatment of inflammatory diseases)
SafeStitch Medical, Inc., has raised $5 million in funding through a new issuance of stock (endoscopic and minimally invasive surgical devices)
Aradigm Corporation has raised $5 million in a private placement (pulmonary drug delivery)
Neosync, Inc., has raised $3.4 million of a planned $10 million funding round according to a regulatory filing (neuro-EEG treatment of depression)
EpiEP, Inc., has raised $1 million in funding (technology for minimally invasive pericardial access in treatment of cardiac arrhythmias)
Baxano, Inc., has raised $30 million in a Series C funding (technology for decompression during spine surgery)
Monteris Medical, Inc., has raised $3.4 million in a round of funding (laser-based thermal therapy for brain surgery)
Voyage Medical has raised $20.6 million of a planned $21.1 million according to a regulatory filing (RF catheter ablation of atrial fibrillation employing visualization system)
Incline Therapeutics has raised $22 million of a planned $43 million round of funding according to a regulatory filing (post-surigical, patient controlled analgesia through drug/device system)
HemoSonics, Inc., has raised $1 million in funding according to a regulatory filing (sonorheometry diagnostic device for bleeding disorders)
Tarsus Medical, Inc., has raised $510,000 in a round of funding (podiatry applications)
Del Palma Orthpedics LLC has raised $1.4 million of a planned $2 million round of funding according to a regulatory filing (orthopedic instrumentation development)
Cayenne Medical, Inc., has raised $3.6 million of a planned $9.54 million funding round (technologies in cruciate ligament reconstruction)
PharmacoPhotonics has raised $1.5 million in funding (device to measure kidney glomerular filtration rate)
SRS Medical Systems, Inc., has raised $3.77 million in funding according to a regulatory filing (devices for measurement of urodynamics and treatment of urinary incontinence)
CAS Medical Systems, Inc., has raised $1.925 million in funding according to a regulatory filing (patient monitoring systems)

Source: MedMarket Diligence, LLC

Reports:

2010 May, Medical Technology Financings

pjd@mediligence.com — Mon, 31 May 2010 08:57:04 -0700

CoRepair, Inc., has raised $4.49 million of a planned $5.73 million round of financing (radiofrequency ablation treatment of congestive heart disease)
Respirics, Inc., has raised $3.7 million of a planned $4.6 million funding round according to a regulatory filing (inhalation-based drug delivery technology)
Entrigue Surgical, Inc., has raised $10.88 million of a planned $11.38 million funding round according to a regulatory filing (surgical instrumentation for ENT)
TearScience has raised $44.5 million in a Series C funding round, according to the company (diagnostic and treatment devices for evaporative dry eye)
CardioMEMS, Inc., has raised $37.9 million in financing, according to the company (implantable wireless sensor for cardiac monitoring)
BIO2 Medical, Inc., has raised $7.5 million in a Series B round (nitinol vena caval filter)
Envoy Medical, Inc., has raised $330K of a planned $16.5 million round of financing (implantable hearing device)
Gynesonics, Inc., has raised $15.12 million in a planned $20.64 million round of financing (device for minimally invasive treatment of uterine fibroids)
Audax Medical, Inc., has raised $551K in a round of financing according to a regulatory filing (surgical instrumentation and osteogenic biomaterials for spine surgery)
NuOrtho Surgical, Inc., has raised $250K toward a planned $1.5 million round of financing according to a regulatory filing (radiofrequency surgical applications in orthopedics)
Pluristem Therapeutics, Inc., has raised $250K in a funding according to a regulatory filing (cell therapies for several severe degenerative, ischemic and autoimmune disorders)
Sequent Medical, Inc., has raised $15.6 million in a round of funding (endovascular treatment of aneurysm)
Small Bone Innovations, Inc. (treatments and technologies for small bones and joints), has received a $12 million investment from Olympus Corporation
Palmaz Scientific Inc., has raised $3 million in a recent funding (nanotech surfaces for implantable medical devices)
XLumena, Inc., has raised $3 million according to a regulatory filing (devices to enable endoscopic ultrasound-guided translumenal therapy)
Breathe Technologies, Inc., has raised $23 million in Series C funding (patient ventilation technology)
Tenaxis Medical, Inc., has raised $780K toward a planned $4.3 million round of financing (sealants and anti-adhesion products for vascular and general surgery)
iRhythm Technologies, Inc., has raised $10 million in funding according to a regulatory filing (cardiac rhythm monitoring)
Leonardo Biosystems, Inc., has raised $1.25 million of a planned $2.5 million round of funding according to a regulatory filing (nanotech-based drug delivery technologies)
ReVision Optics, Inc., has raised $35 million in funding according to a regulatory filing (implanted lens replacement for patients with presbyopia)
Arsenal Medical, Inc., has raised $10 million in funding according to a regulatory filing (biomaterials-based therapeutics based on bioactive composites)
O2 MedTech, Inc., has raised $2 million in funding according to a regulatory filing (early stage medical device company)
Oncoscope, Inc., has raised $1.2 million of a planned $1.5 million round of funding according to a regulatory filing (optical biopsy)
Inova Labs, Inc., has raised $10 million in a private placement funding (portable oxygen concentrator)
Celula, Inc., has raised $15 million in a recent funding (noninvasive prenatal diagnostics)
CardioDx, Inc., has raised $34.56 million in Series D funding toward a planned $44.54 million round (cardiovascular genomic diagnostics, including to identify obstructive coronary artery disease)
BioControl Medical Ltd. (implantable nerve stimulation device) will receive a $70 million investment from Medtronic, Inc.
Biomedical Structures, LLC_ has raised $3.75 million in funding (biomaterials and textikes for medical devices)
Delphinus Medical Technologies, Inc., has raised $8 million in funding (ultrasonic breast cancer detection device)
RF Surgical Systems, Inc., has raised $2.5 million of a planned $5 million round of financing (technologies to detect and prevent retained surgical sponges)
Altura Medical, Inc., has raised $8 million in funding according to a regulatory filing (low profile stent graft for abdominal aortic aneurysm)
HepaLife Technologies, Inc., has raised $12.025 million in funding according to two regulatory filings (bioartificial liver)
SpineFrontier, Inc., has raised $500K according to a regulatory filing (surgeon-innovated technologies in spine surgery)
Pathfinder Therapeutics, Inc., has raised $3 million of a planned $4 million funding round according to a regulatory filing (intraoperative surgical navigation)
Keraplast Technologies, Inc., has raised $2.5 million of a planned $5 million funding round (wound healing and bone regeneration based on keratin)
Cohera Medical, Inc., has raised $12.2 million of a planned $19.94 million round of funding (bioabsorbable surgical adhesive)
Dune Medical Devices Ltd has raised $7.7 million of a potential $12.7 million round of funding (device for rapid detection of breast cancer during surgery)

Source: MedMarket Diligence, LLC

Reports:

2010 April Medical Technology Financings

pjd@mediligence.com — Fri, 30 Apr 2010 09:00:17 -0700

CleveX, Inc., has received the second tranche of its $1.7 million Series B funding round (device to facilitate skin biopsies)
Diamyd Medical AB has raised $4.89 million (35 million SEK) in funding (pharmaceuticals for the treatment of autoimmune diabetes and its complications)
Exos Corp. has raised $925K of a planned $1 million round of financing according to a regulatory filing (polymer based cast alternative)
Small Bone Innovations, Inc., has raised $12 million in financing according to a regulatory filing (technologies focused on small bone & joint)
Viacor, Inc., has raised $6.58 million in financing through a debt and securities sale (catheter-based treatment of valve disease)
WaveRx, Inc., has raised $500K in an equity offering according to a regulatory filing (medical device technology to treat disorders of the nail and skin)
Hemosphere, Inc., has raised $9.3 million in a Series A funding (technology to aid in vascular access as in renal dialysis)
Svelte Medical has raised $3 million to complete its Series A financing, adding to the $6 million received in November 2009 (developing a non-thrombogenic, non-inflammatory drug-eluting stent)
Stratatech, Inc., has raised $3 million in funding according to a regulatory filing (genetically engineered skin substitute)
LaZure Scientific has raised $2 million of a planned $3 million funding round (treatment of cancer via low intensity electric fields)
Articulinx, Inc., has raised $10 million in a second round of funding (device-based treatment of osteoarthritis)
OrthoHelix Surgical Designs Inc., has added $4.6 million to its Series C funding round (implants and instruments for foot, ankle, hand and wrist surgeries)
VasoNova, Inc., has raised $2.24 million of a planned $7.8 million round of funding (ultasound guidance for vascular access devices)
Exsulin Corp. has raised $120K toward a planned $1.5 million funding round (pancreatic islet cell regeneration for Type 1 diabetics)
Denali Medical has raised $4 million according to a regulatory filing (medical device incubator)
Hyperbranch Medical Technology, Inc., has raised $2.1 million in funding according to a regulatory filing (products, including sealants, for use in ocular surgery)
Veran Medical Technologies, Inc., has raised $950K toward a planned $1.945 million funding round (image guidance system in interventional radiology)
Asalus Medical Instruments Ltd has raised $687K (£450K) in its first funding round (instruments to assist in laparoscopic surgery)
Bovie Medical has raised $3 million via private placement (electrosurgical instruments)
CardioFocus, Inc., has raised $5 million in funding according to a regulatory filing (ablation treatment of cardiac disorders, atrial fibrillation, AFib heart arrhythmia)
Soft Tissue Regeneration, Inc., has raised $500K from Connecticut Innovations (tissue regeneration of anterior cruciate ligament)
Pluromed, Inc., has raised #1.1 million of a planned $3.9 million funding round (hydrogel products used during lithotripsy and other procedures)
Tissue Genesis, Inc., has raised $1.12 million of a planned $9 million funding round (advanced tissue engineering and cell therapy based on adipose tissue)
Cytomedix, Inc., has raised $3.65 million in a funding round according to a regulatory filing (tissue regeneration in wound care, angiogenesis, and inflammation)
Facet Solutions, Inc., has raised $2.12 million in a funding round according to a regulatory filing (devices for facet arthroplasty)
ALung Technologies, Inc., has raised $2.8 million in a recent funding (respiratory assistance technology to provide catheter-based oxygenation via femoral or jugular vein)
Nevro Corp. has raised $20 million in funding according to a regulatory filing (neuromodulation therapies for indications such as chronic pain)
Spiration, Inc., has raised $6.5 million in a funding round according to a regulatory filing (devices for the treatment of emphysema)
InTouch Technologies, Inc., has raised $10 million of a planned $11 million round of funding according to a regulatory filing (remote presence technologies)
NeoVista, Inc., has raised $3 million in a round of funding according to a regulatory filing (technologies for the treatment of wet age-related macular degeneration)
Biomimedica has raised $600K of a planned $2.4 million round of financing (synthetic cartilage for joint repair)
Harbinger Medical, Inc., has raised $550K in a round of funding according to a regulatory filing (electrocardiograph)

Source: MedMarket Diligence, LLC

Reports:

2010 March, Medical Technology Financings

pjd@mediligence.com — Wed, 31 Mar 2010 10:17:53 -0700

Isis Biopolymer has raised $3 million in funding according to a regulatory filing (transdermal drug delivery)
Access Closure has raised $10 million in funding (closure and sealing of femoral puncture site following interventional procedure)
Reverse Medical Corp. has received $12.8 million in a funding round according to a regulatory filing (embolic protection systems)
TransMedics, Inc., has raised $36 million a funding round (support system for donor organs)
Soluble Systems, LLC, has raised $1.3 million in funding according to a SEC filing (advanced sterile wound dressings)
Carticept Medical, Inc., has raised $20 million in a Series B round of financing (synthetic cartilage implant)
OsteoSpring Medical, Inc., has received $950K of a planned $2.5 million financing round according to a regulatory filing (osteobiologics under development by former President/CEO of NeuColl)
Solta Medical, Inc., has raised $4.75 million of a planned $15.5 million round of financing according to a regulatory filing (radiofrequency-based technology for cosmetic skin procedures)
Veryan Medical Ltd has raised $5.5 million (€4 million) in a round of financing (stents based on swirling blood flow)
FluidNet Corp. has raised $9.08 of a planned $9.92 million funding round (infusion delivery device)
Amedica Corp. has raised $11.5 million of a planned $30 million funding round according to a regulatory filing (orthopedic biomaterials)
Cheetah Medical, Inc., has raised $20 million in Series B funding (non-invasive hemodynamic monitoring)
Rhythmia Medical Inc. raised nearly $2.7 million in a Series B funding (heart mapping device to guide arrhythmia ablation procedures)
EMKinetics, Inc., has raised $2.8 million of a planned $3.35 million round of funding (neuromodulation, initially for urinary incontinence)
Spinal Restoration, Inc., has raised $20 million in a round of funding according to a regulatory filing (non-surgical system for treatment of chronic back pain)
NonLinear Technologies Ltd has raised $8.8 million in funding (motion preservation and percutaneous options in spine surgery)
Applied StemCell has raised $1.88 million of a $2.45 million funding according to a regulatory filing (Stem cell culture, cell lines, assays, cell replacement therapies)
Arsenal Medical, Inc., has raised $1 million in financing (biomaterials-based therapeutics based on bioactive composites)
Rotation Medical, Inc., has raised $3.88 million of a planned $4.41 million round of investment (undisclosed medical device technology)
Z&Z Medical Holdings, Inc., has raised $5 million in funding according to a regulatory filing (dissolution of arterial plaques via elevation of bile salts)
Sequent Medical, Inc., has raised $1 million in funding according to a regulatory filing (devices for endovascular treatment of neuovascular disease)
SmartCells, Inc., has raised $1.75 million of a planned $4 million funding round according to a regulatory filing (insulin bound to a "polymer-therapeutic" to produce glucose-concentration-specific insulin release)
Novocell, Inc., has raised $304K of a planned $2 million round of funding according to a regulatory filing (encapsulated cellular transplants for the treatment of diabetes and other diseases)
Hemosphere, Inc., has raised $9.35 million in funding according to a regulatory filing (vascular access device)
OxyBand Technologies, Inc., has raised $700K of a planned $11 million round of funding (oxygen-based wound dressing)
Anulex Technologies, Inc., has raised $3.8 million in funding according to a regulatory filing (spine surgery devices)
White Pine Medical, Inc., has raised $1 million of a planned $57 million (yes, $57M) total offering (late stage medical device acquisitions)
JenaValve Technology GmbH has raised $25.65 million ( €19 million) in a Series B round of financing (minimally invasive aortic valve replacement)
Reverse Medical Corp. has raised $14 million in a Series B funding round (microcatheters for treatment of neurovascular disorders)
Imthera Medical, Inc., has raised $520K of a planned $3.5 million funding round (neurostimulation device for treatment of obstructive sleep apnea)

Source: MedMarket Diligence, LLC

Reports:

2010 February, Medical Technology Financings

pjd@mediligence.com — Sun, 28 Feb 2010 10:14:19 -0700

Valtech Cardio Ltd. has received $17.8 million in Series B funding (minimally invasive surgical and transcatheter mitral valve repair and replacement technologies)
Tepha, Inc., has raised $3 million in financing according toa regulatory filing (polymers and elastomers used in medical devices)
OrthAlign has received $5.2 million in a Series A2 financing (computer-assisted knee surgery system)
Resoimplant GmbH has received $3.5 million in its third round of financing (bioabsorbable orthopedic implants)
CytoSolv Inc. has raised $500K in seed financing (development of choroid plexus protein technology for wound management)
CardioInsight Technologies Inc. has raised $6 million in Series B financing (non-invasive cardiac mapping)
MicroTransponder, Inc. has raised $7 million in a Series B financing (wireless neurostimulation for treatment of chronic pain, other neuro)
ALung, Inc., raises $3.3 million in an undisclosed round of financing (intravascular lung oxygenation device to replace/supplement hospital ventilators)
Calibra Medical Inc. has raised $9.2 million of a planned $32.3 million round of financing (portable insulin delivery device)
InSight Medical Technologies, Inc., has raised $1.06 million of a planned $2.08 million round of funding (device for epidural anesthesia)
SpineAlign Medical, Inc., has raised $1.64 million of a planned $6.9 million funding round according to a regulatory filing (vertebral body spinal replacement)
Intuity Medical, Inc., has raised $40.68 million of a planned $64.22 million funding round according to a regulatory filing (simplified blood glucose monitor)
Parcus Medical, Inc. has raised $1.3 million in a planned $2 million round of funding (surgical instrumentation)
Flexible Medical Systems, LLC, has raised $1.34 million in a new round of funding (remote transdermal biomonitoring)
Salutaris Medical Devices, LLC, has raised $1.3 million in funding according to a regulatory filing.
Vyteris, Inc., has raised $1.06 million of a planned $7 million funding round according to a regulatory filing (transdermal drug delivery)
Adhezion Biomedical has raised $2.5 million of a planned $3.4 million round of funding, according to a regulatory filing (cyanoacrylate-based adhesives and sealants)
Imricor Medical has raised $3.07 million in funding according to a regulatory filing (ablation catheter for treatment of atrial fibrillation)
Intrinsic Therapeutics, Inc., has raised $18 million in funding according to a regulatory filing (treatment of soft tissue injuries of the spine)
Pulmonx has raised $32 million in a new round of funding (minimally invasive devices for treatment of pulmonary disorders)

Source: MedMarket Diligence, LLC

Reports:

2010 January, Medical Technology Financings

pjd@mediligence.com — Sun, 31 Jan 2010 10:28:24 -0800

Proteus Biomedical, Inc., has raised $25.45 million in a new funding round according to a regulatory filing (management of congestive heart failure)
HistoSonics, Inc., has raised an additional $6 million in funding, bringing its Series A round to $11 million (ultrasound based tissue ablation for BPH, others)
Intuity Medical, Inc., has raised $64 million in Series D financing (integrated blood glucose monitor)
CeQur SA has raised $30 million in a Series A funding (subcutaneous insulin patch for Type 2 diabetes)
CircuLite, Inc., has closed a Series C funding of $32.5 million (micro-pump for circulatory support in congestive heart failure)
Michelson Diagnostics Ltd has received $1.1 million in new funding (developing optical coherence tomography)
ValenTx Inc. has raised $22 million in a Series B funding ( less-invasive, implantable medical device to address morbid obesity)
Neuralstem, Inc., has raised $1.5 million in financing (stem cell therapy in CNS disorders including Ischemic Paraplegia, Traumatic Spinal Cord Injury, ALS and Parkinson’s Disease)
MicroCHIPS, Inc., has raised $16.5 million in Series C financing (wireless implants for diagnostics and drug delivery)
GI Dynamics, Inc., has raised $15 million in Series C financing from sole investor Medtronic (EndoBarrier Gastrointestinal Liner for treatment of obesity)
MiMedx, Inc., has raised $5 million in a private placement funding (biomaterials for tissue augmentation and repair)
Heart Force Medical Inc., has raised $4.8 million in funding (developing digital Ballistocardiograph for non-invasive cardiac assessment)
Salient Surgical, Inc., has raised $15 million in funding (RF-based system for wound sealing/closure)
Microfabrica, Inc., has raised $22.5 million in Series B funding (minimally invasive medical devices)
Endogun Medical Systems, Ltd. (changing name to Israel Biomedical Innovations), has raised $12.5 in funding (minimally invasive suturing)
TVA Medical, Inc., has raised $2.6 million in a Series A financing round (minimally invasive treatments for end stage renal disease)
Crospon has raised $2.9 million (€2 million) in funding (diagnostic tool for use in gastroesophageal reflux disease)
Tandem Diabetes has raised $31 million in funding, bringing its current round to $52.3 million (insulin pumps)
Apama Medical, Inc., has raised $1.1 million in seed funding (treatment of atrial fibrillation)
Solta Medical, Inc., has raised $17.2 in funding (radiofrequency and laser based aesthetic treatments of skin)
Advanced Cardiac Therapeutics, Inc., has raised $5 million in Series B funding (irrigated cardiac ablation systems)
Dfine, Inc., has raised $2.83 million in funding according to a regulatory filing (treatment of vertebral compression fractures)
Neuralieve, Inc., has raised $3.89 million of a planned $7.5 million round of funding according to a regulatory filing (non-invasive device for treatment of neurological problems, including migraine)
Promethean Surgical Devices, Inc., has raised $3.68 million in funding according to a regulatory filing (polymer technology for surgical adhesives and implants)
Cerevast Therapeutics, Inc., has raised $2 million in funding according to a regulatory filing (sonolysis for treatment of vascular thrombus disorders)
CuMed LLC has raised $4 million in funding according to a regulatory filing (undisclosed nanotech medical technology)
Windmill Cardiovascular Systems, Inc., has raised $1 million in funding according to a regulatory filing (left ventricular assist device)
CHF Solutions, Inc., has raised $1.82 million in funding according to a regulatory filing (treatment of congestive heart failure)
InfraReDx, Inc., has raised $10 million in funding according to a regulatory filing (identification and stabilization of vulnerable plaque)
EBS Technology GmbH has raised $4.34 million (€3 million) in a Series B financing (devices for treatment of neurological deficit from stroke and trauma)
BioPoly LLC has raised $2 million in its first round of financing (polymer for orthopedic implants)
Enteromedics, Inc., has raised $4.8 million in funding through sale of its stock to institutional investors (device therapies for vagal-mediated disorders)
Cardiorobotics, Inc., has raised $5 million funding according to a regulatory filing (surgical devices used to enhance endoscopic surgery)
ConforMIS, Inc. has raised $2.16 million in financing according to a regulatory filing (patient-specific implants and instrumentation)
Pulmonx, Inc., has raised $11.5 million in bridge round financing (minimally invasive devices for treatment of pulmonary disorders)
Arsenal Medical, Inc., has raised $2 million in funding according to a regulatory filing (biomaterials-based therapeutics based on bioactive composites)
InSite Medical, Inc., has raised $1 million of an expected $2 million in funding (epidural anaesthesia delivery)
Cohera Medical, Inc., has raised $10 million in a planned $25 million Series C financing round according to Dow Jones VentureWire (surgical glue used in aesthetic procedures)
Solta Medical, Inc., has raised $17.2 million in funding according to a regulatory filing (radiofrequency and laser aesthetic treatment of skin)
Luna Innovations, Inc., has raised $7.1 million in funding according to a regulatory filing (optical components in medical device, equipment and other applications)
Amedrix GmbH has raised $987K in seed financing (collagen-based implants for repair of soft tissue defects)
Axogen, Inc., has raised $3.36 million in financing, toward a planned $4.7 million round, according to a regulatory filing (nerve grafts to repair and regenerate damaged peripheral nerves)
Minerva Surgical, Inc., has raised $1 million in financing according to a regulatory filing (endometrial ablation of abnormal uterine bleeding)
NeoGraft, Inc., has raised $6.3 million in financing according to a regulatory filing (new device for structural support of veins for arterial vein grafts)
OrthoAlign, Inc., has raised $5.2 million in a Series A2 tranche (computer-assisted surgical device in orthopedic surgery)
Cellular Dynamics International, Inc., has raised $31.3 million in funding according to a regulatory filing (pluripotent stem cells, such as cardiomyocytes, used for drug discovery)
NeoMend, Inc. has received $30 million in funding (products used in sealing of surgical wounds)

Source: MedMarket Diligence, LLC

Reports:

2009 December, Medical Technology Financings

pjd@mediligence.com — Thu, 31 Dec 2009 06:27:44 -0800

Hepa Wash GmbH has raised $5.74 million (€ 3.8 million in a Series A financing round (liver assist device)
Neostim, Inc., has raised $1 million according to a regulatory filing (neuromodulation of nervous system-mediated disorders)
Advanced Cell Technology, has raised $2.77 million in financing from debt and options, according to a regulatory (human embryonic stem cell technology)
Echo Therapeutics, Inc., has raised $563K in a funding round according to a regulatory filing (ultrasound-based transdermal drug delivery)
Apnex Medical, Inc., has raised $14 million in its second round of funding (implantable device for treatment of obstructive sleep apnea)
Nautilus Neurosciences, Inc., has raised $13.08 million according to a regulatory filing.
TransMedics, Inc., has raised $3.57 million according to a regulatory filing (preservation system for organ transplant)
Medisse BV has received an undisclosed sum in a financing round from BioGeneration Ventures (biomaterials for resorbable implants in a range of clinical applications)
TiGenix NV has raised $11.33 million (€ 7.7 million) in a private placement (products for tissue repair and regeneration)
Monterey Devices, Inc., has raised $2.55 million according to a regulatory filing (drug delivery systems)
Ophthotech Corp. raises $30 million in Series B financing (biopharmaceutical treatments for wet and dry age-related macular degeneration)
AxioMed Spine Corp. has raised $6.4 million toward a projected total $18.5 million Series C round (spinal disc replacements)
Hoana Medical, Inc., has raised $10.2 million in an oversubscribed Series C financing (system for non-contact measurement of vital signs)
ImplicitCare LLC, has raised $1.48 million according to a regulatory filing (surgical suture system)
Asthmatix Inc. has raised $27 million in a Series C financing (medical device for outpatient treatment of asthma)
Taris Biomedical, Inc., has raised $5 million according to a regulatory filing (device for localized drug delivery)
Cardo Medical, Inc., has raised $6.2 million according to a regulatory filing (reconstructive products for orthopedic surgery)
California Stem Cell, Inc., has raised an undisclosed sum in a second round of financing (stem cell treatments for spinal cord injuries)
EnzySurge Ltd. has raised $2.5 million in a round of financing (products for wound management)
Cambridge Heart has raised $1.85 million in a financing round according to a regulatory filing (noninvasive cardiac diagnostics)
Syncro Medical Innovations, Inc., has raised $500K in a financing round according to a regulatory financing (enteral feeding tube)
CleveX, Inc., has raised $696K in a financing round according to a regulatory filing (skin biopsy, closure and repair)
Bioject Medical Technologies, Inc., has raised $1.2 million in a financing round according to a regulatory filing (needlefree injection of liquid medications)
HistoSonics, Inc., has raised $5 million in financing according to a regulatory filing (ultrasound based tissue ablation for BPH, others)
Coapt Systems, Inc., has raised $3.72 million in a funding rounding including debt, securities, warrants and rights (soft tissue fixation in aesthetic applications)

Source: MedMarket Diligence, LLC

Reports:

2009 November, Medical Technology Financings

pjd@mediligence.com — Mon, 30 Nov 2009 07:12:36 -0800

Activaero GmbH has raised $16 million in a Series A financing (pulmonary drug delivery device)
SpinalMotion, Inc., has raised $27.4 million in a Series C financing (therapeutic devices for treatment of chronic pain)
On-Q-ity has raised $21 million in a Series A round (cancer cell detection and testing platform)
Novaray Medical, Inc., has raised $5.9 million according to a regulatory filing (digital x-ray technology for cardiac catheterization and other applications)
Facet Solutions, Inc., has raised $3.6 million according to a regulatory filing (surgical devices for spine disorders)
Light Sciences Oncology has raised $11.8 million in financing via warrants, in addition to $23 million in credit (drug/device combination for killing malignant tumors)
SpectraScience has raised $4.3 million in financing through a private placement (fluorescence based technology for cancer detection)
Eso-Technologies, Inc., has raised $1 million in funding from angel investors (esophageal monitoring device to replace peripheral artery catheter)
Promethera Biosciences, Inc., has raised € 5.3 million ($7.94 million) in a Series A funding (stem cell therapy)
Checkpoint Surgical, LLC, has raised $1.1 million in a round of financing (handheld disposable nerve stimulator)
Hamilton Thorne, Inc., has raised $2.1 million in a private placement (stem cell therapy research)
Ortho Kinematics has raised $3.5 million in a funding round (spine motion analysis diagnostics)
Fate Therapeutics, Inc., has raised $30 million in a Series B financing (induced pluripotent stem cell technology platform)
Cardo Medical, Inc., has raised $6.2 million in a private placement (reconstructive orthopedic and spinal surgery products)
NuOrtho Surgical, Inc., has raised $1 million in a second round of funding (tissue preservation for orthopedic procedures)
Entellus Medical, Inc., has raised $30 million in a series D funding (less invasive treatment of sinusits)
Onset Medical has raised $1.2 million of a planned $12.1 million funding round (percutaneous access products)
Trireme Medical, Inc., has raised nearly $7.1 million of a planned $14 million funding round (delivering prostheses to luminal bifurcations)
Corindus, Inc., has raised $5.3 million of a planned $10 million Series C funding (robotic systems to assist with guidewires for placement of vascular stents)
Calibra Medical, Inc., has raised $1.4 million in a funding round according to a regulatory filing (insulin delivery device)
Echo Therapeutics, Inc., has raised $3 million in a funding round according to a regulatory filing (ultrasound-based transdermal drug delivery)
Humacyte, Inc., has raised $7 million in debt financing according to a regulatory filing (tissue scaffolding technology)
Cardiola Ltd. has added $4 million to its Series E financing, bringing the round to $6.3 million (muscular counter pulsation for treatment of heart failure)
Svelte Medical Systems, Inc., has raised $6 million toward a planned $9 million funding round according to a regulatory filing (developing a non-thrombogenic, non-inflammatory drug-eluting stent)
Entrigue Surgical, Inc., has raised $3.2 million according to a regulatory filing (biomaterials and instruments for head and neck surgery)
Spine View, Inc., has raised $6.3 million according to a regulatory filing (technologies focused on improving spinal decompression and fusion)
EndoGastric Solutions, Inc., has raised $21.5 million on a Series E financing (endoluminal procedures for upper gastric conditions)
Apnex Medical, Inc., has raised $14.05 million of a planned $19.05 million round of funding (sleep apnea implantable treatment device)
BaroSense, Inc., has received and undisclosed amount in funding from iNovia Capital in a Series B round (minimally invasive treatment of obesity)

Source: MedMarket Diligence, LLC

Reports:

2009 January, Medical Technology Financings

pjd@mediligence.com — Sat, 31 Jan 2009 09:22:56 -0800

Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million (antibiotics for gram negative resistant organisms)
ALung Technologies raises $1M of potential $2.5mm financing (intravascular lung oxygenation device)
SynergEyes, Inc. Raises $13.3 Million in ‘Series C’ Financing (hybrid contact lenses)
Arcxis Biotechnologies(R) Secures Series B Financing (undisclosed amount) — molecular diagnostics
Diagnosoft(R) Secures $4 Million in Financing (MRI image analysis)
DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round (signal interfering DNA (siDNA) to fight treatment resistant cancers)
The Foundry Announces New Partners and Completion of Series A Financing for Eleventh Company (stealth technology company)
Medical device co SteadyMed raises $2M (medical-device company developing devices for delivering injectable therapeutic drugs for pain relief, diabetes and other chronic conditions.)
Avantis Medical Systems, Inc. Raises $10 Million in Series C Funding (catheter-based endoscopic devices)
Hydra Biosciences Raises $22 Million in Series D Financing (molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels)
Alter-G Secures $8 Million in Series B Financing from Versant Ventures (FDA-approved "anti-gravity" treadmill for rehabilitation)
Singulex Closes $19 Million Financing Round (diagnostic assays to detect specific biomarkers in complex samples; or diagnosis and drug development)
InSet Technologies Completes $25 Million Financing (implantable pumps to delivery a wide range of therapeutics)
Acclarent, Inc. Closes $26 Million Financing (endoscopic, catheter-based tools for ENT)
Kythera Biopharmaceuticals Secures Additional $10 Million, as part of $40 million Series C (aesthetic dermatology)
Algeta ASA (Oslo, Norway) receives $35 million in private placement (cancer therapeutics)
Opsona Therapeutics receives $23 million Series B (biotech treatment/prevention of autoimmune and inflammatory diseases)
Andromeda Biotech receives $10.5 million in funding from Teva Pharmaceutical Industries (juvenile diabetes treatment)
Ascension Orthopedics secured $21 million in a Series D financing in January (pyrocarbon orthopedic implants for small skeletal joints)
Sopherion Therapeutics, Inc. Secures $55 Million in Series C Funding (non-glycosylated liposomal doxorubicin anti-cancer agent)
NanoBio Corporation Raises $12 Million in Series B Financing (nano-scale drug-delivery systems)
GI Dynamics Closes an Additional $15 Million in Series C Financing (devices for gastric bypass alternative treatment for obesity)
SEMPRUS BioSciences Closes $8M Series A Financing (medical device surface technologies to reduce infection, resist clot formation and control restenosis)
Primaeva Medical Nets $6M Series C Venture Financing (medical device technologies in aesthetics)
Eiger Biopharma Raises $7.1 Million 'A' Round Funding (start-up biotechnology company developing antiviral therapies)
Selecta Biosciences, Inc. Closes $15.1M Series B Financing (nanoparticle immunomodulatory drugs)

Source: MedMarket Diligence, LLC

Reports: